Source: Manufacturing Chemist

Sterling: Sterling Pharma broadens its ADC development services with 10m investment into Deeside site

The CDMO's ADC development and manufacturing facility in Deeside has more than doubled in capacity, with a new Grade C cleanroom dedicated to ADC manufacturing

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Kevin Cook's photo - President & CEO of Sterling

President & CEO

Kevin Cook

CEO Approval Rating

88/100

Read more